Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Lars Lannfelt & BioArctic

4 shared events · Importance 3 · Last updated May 28, 2026

Importance
3
Shared Events
4
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
71
Business
Lars Lannfelt: Lars Lannfelt was re-elected as an ordinary board member of BioArctic.
BioArctic: BioArctic held its Annual General Meeting, making several key resolutions including dividend payment, board re-elections, and approval of an incentive program, which directly impacts its corporate governance and shareholder value.
May 28, 2026 · 9 articles
44
Tech
Lars Lannfelt: Lars Lannfelt is the researcher whose work at Uppsala University led to the discovery of the Arctic mutation and the development of Leqembi.
BioArctic: BioArctic is the central actor, announcing the first Swedish patient treated with Leqembi and holding Nordic commercialization rights with Eisai. The launch supports its royalty and milestone revenue stream, though the negative NT-radet reimbursement recommendation limits near-term Swedish sales.
Sep 22, 2026 · 7 articles
30
Business
Lars Lannfelt: Professor Lars Lannfelt's discovery of the Arctic mutation in Alzheimer's disease formed the basis for the development of Lecanemab by BioArctic.
BioArctic: BioArctic, in collaboration with Eisai, developed Lecanemab and is set to receive approximately SEK 880 million in royalties from the projected sales, indicating a positive financial outlook for the company.
May 15, 2026 · 6 articles
0
Regulatory
May 08, 2026 · 14 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Lars Lannfelt and BioArctic interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.